Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lanthanum Carbonate vs Calcium Acetate vs Diet in CKD Stage 3/4
NCT01357317Phase 3Unknown
- Sponsor
- Salem VA Medical Center
- Start
- Jun 2011
- Primary completion
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of lanthanum carbonate in hyperphosphatemia (3 arms), sponsored by Salem VA Medical Center. Primary endpoints: Change in Serum Phosphorus at 1 year, Change in Urine Phosphorus at 1 year and 5 more. Status: unknown.
02
Drugs
lanthanum carbonate
03
Conditions
hyperphosphatemia
Beyond the preview
Go deeper on NCT01357317.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01357317.